Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ARDX stock hub

Ardelyx, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ARDXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ARDX

In the news

Latest news · ARDX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E93.1

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-39.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-26.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ARDX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001437402
Company name	Ardelyx, Inc.
Country	United States
Country code	US
Cusip	039697107
Employees	489
Employees Change	94%
Employees Change Percent	23.8
Enterprise value	$1.7B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2014-06-19
Isin	US0396971071
Last refreshed	2026-05-10
Market cap	$1.7B
Market cap category	Small-Cap
Price	$6.78
Price currency	USD
Rev Per Employee	874,599.18x
Sector	Healthcare
Sic	2834
Symbol	ARDX
Website	https://www.ardelyx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.47%
EV Sales Forward	2.81x
EV/Sales	3.91x
FCF yield	-2.24%
Forward P/E	93.13x
P/B ratio	11.27x
P/S ratio	3.92x
PS Forward	2.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-8.75%
EBITDA Margin	-7.96%
Gross margin	74.56%
Gross Profit	$318.9M
Gross Profit Growth	27.9%
Gross Profit Growth Q	48.22%
Gross Profit Growth3 Y	143.64%
Net Income	$-58.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-13.55%
Profit Margin	-13.58%
Profit Per Employee	$-118,732
ROA	-5.11
Roa5y	-20.52
ROCE	-9.48
ROE	-39.46
Roe5y	-66.98
ROIC	-26.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.7%
Cagr1y	83.32%
Cagr3y	13.72%
Cagr5y	0.12%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	18.24x
Revenue Growth Q	27.47x
Revenue Growth Quarters	9x
Revenue Growth Years	7x
Revenue Growth3 Y	89.29x
Revenue Growth5 Y	101.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.94
Assets	$504.5M
Cash	$238.1M
Current Assets	$381.9M
Current Liabilities	$109.6M
Debt	$234.1M
Debt Equity	$1.58
Equity	$148.6M
Interest Coverage	-1.29
Liabilities	$355.9M
Long Term Assets	$122.6M
Long Term Liabilities	$246.3M
Net Cash	$3.9M
Net Cash By Market Cap	$0.24
Net Cash Growth	-87.79%
Net Debt Equity	$-0.03
Tangible Book Value	$148.6M
Tangible Book Value Per Share	$0.6
WACC	7.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.49
Inventory Turnover	4.68
Net Working Capital	$35.7M
Quick ratio	2.93
Working Capital	$272.3M
Working Capital Turnover	$1.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.63%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-6.74%
1Y total return	83.24%
200-day SMA	6.04
3Y total return	47.07%
50-day SMA	6.12
50-day SMA vs 200-day SMA	50over200
5Y total return	0.59%
All Time High	35.48
All Time High Change	-80.89%
All Time High Date	2014-12-04
All Time Low	0.49
All Time Low Change	1,283.11%
All Time Low Date	2022-06-16
ATR	0.36
Beta	0.61
Beta1y	1.7
Beta2y	0.75
Ch YTD	16.3
High	7.2
High52	8.4
High52 Date	2026-01-23
High52ch	-19.29%
Low	6.71
Low52	3.21
Low52 Date	2025-05-15
Low52ch	111.22%
Ma50ch	10.84%
Premarket Change Percent	0.29
Premarket Price	$7
Premarket Volume	25,008
Price vs 200-day SMA	12.29%
RSI	58.91
RSI Monthly	55.66
RSI Weekly	54.73
Sharpe ratio	1.2x
Sortino ratio	2.31
Total Return	-2.63%
Tr YTD	16.3
Tr1m	13.95%
Tr1w	-1.45%
Tr3m	-7.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	3
Analyst Price Target Top	$15.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.14
Earnings Revenue Estimate	92,388,744x
Earnings Revenue Estimate Growth	24.66x
Operating Income	$-37.4M
Operating margin	-8.75
Price target	$15.14
Price Target Change	$123
Price Target Change Top	$131

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	219,482,250%
Float Percent	88.85%
Net Borrowing	48,668,000
Shares Insiders	3.85%
Shares Institutions	62.97%
Shares Out	247,029,387
Shares Qo Q	0.92%
Shares Yo Y	2.63%
Short Float	10.94%
Short Ratio	7.06
Short Shares	9.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-88.5M
Average Volume	4,259,489.45x
Bv Per Share	0.6
CAPEX	$-1.2M
Ch10y	-6.74
Ch1m	13.95
Ch1w	-1.45
Ch1y	83.24
Ch3m	-7.38
Ch3y	47.07
Ch5y	0.59
Ch6m	21.29
Change	-2.87%
Change From Open	-3.69
Close	6.98
Days Gap	0.86
Depreciation Amortization	3,372,000
Dollar Volume	39,751,933.3
Earnings Date	2026-04-30
Earnings Time	amc
EBIT	$-37.4M
EBITDA	$-34M
EPS	$-0.24
F Score	2
FCF	$-37.5M
FCF EV Yield	-2.24x
FCF Per Share	$-0.15
Financing CF	58,469,000
Fiscal Year End	December
Founded	2,007
Income Tax	$118,000
Investing CF	-21,805,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-19
Ma150	6.13
Ma150ch	10.53%
Ma20	6.42
Ma20ch	5.66%
Net CF	401,000
Next Earnings Date	2026-08-03
Open	7.04
Optionable	Yes
Position In Range	14.29
Post Close	6.78
Postmarket Change Percent	-0.44
Postmarket Price	$6.75
Ppne	6,435,000
Pre Close	6.98
Price Date	2026-05-08
Ptbv Ratio	11.27
Relative Volume	1.38x
Revenue	427,679,000x
SBC By Revenue	11.93x
Share Based Comp	51,032,000
Tax By Revenue	0.03x
Tr6m	21.29%
Us State	Massachusetts
Volume	5,863,117
Z Score	0.73

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ARDX pay a dividend?

Capital-return profile for this ticker.

Performance

ARDX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ARDX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+63.0%

Float: +88.8% of shares outstanding

Insider ownership

+3.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ARDX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.9

Neutral momentum band

Price vs 200-day MA

+12.3%

50/200-day relationship not available

Beta (5Y)

0.61

Less volatile than the market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ARDX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ARDX stock rating?

Ardelyx, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ARDX analysis?

The full report lives at /stocks/ARDX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ARDX?

The latest report frames ARDX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ARDX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.